RhumbLine Advisers
KYTH

RhumbLine Advisers’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

RhumbLine Advisers’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-25,811
Closed -$1.94M – 3067
2015
Q3 		$1.94M Buy
25,811
+2,894
+13% +$216K 0.01% 1341
2015
Q2 		$1.73M Buy
22,917
+7,090
+45% +$380K 0.01% 1516
2015
Q1 		$794K Buy
15,827
+2,415
+18% +$101K ﹤0.01% 2005
2014
Q4 		$465K Sell
13,412
-375
-3% -$13.1K ﹤0.01% 2318
2014
Q3 		$452K Sell
13,787
-350
-2% -$12.3K ﹤0.01% 2272
2014
Q2 		$542K Buy
14,137
+4,494
+47% +$157K ﹤0.01% 2230
2014
Q1 		$383K Sell
9,643
-200
-2% -$8.95K ﹤0.01% 2388
2013
Q4 		$367K Buy
9,843
+690
+8% +$28.6K ﹤0.01% 2449
2013
Q3 		$418K Buy
9,153
+1
+0% +$30 ﹤0.01% 2330
2013
Q2 		$248K Buy
+9,152
New +$209K ﹤0.01% 2813

RhumbLine Advisers's KYTH Position: Q4 2015 in Review

RhumbLine Advisers sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 25,811 shares — an estimated $1.94M sold.

RhumbLine Advisers first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $1.94M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • RhumbLine Advisers reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • RhumbLine Advisers sold 25,811 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $1.94M.
  • RhumbLine Advisers first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • RhumbLine Advisers's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.94M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on RhumbLine Advisers's 13F filing for Q4 2015, filed 3 Feb 2016.